高分辨率熔解曲线分析直接检测痰标本中结核分枝杆菌的利福平与异烟肼耐药性
本研究评估高分辨率熔解曲线分析(HRM)直接检测痰标本中耐多药结核(MDR-TB)的效用。以DNA测序为金标准,在99份培养阳性痰标本(含84份涂片阴性)中验证,HRM检测利福平、katG和inhA耐药灵敏度在涂片阴性样本分别为89%、85%和100%,涂片阳性均为100%,特异性均为100%。
要点
- HRM可快速直接检测痰标本中结核分枝杆菌的利福平和异烟肼耐药性。
- 涂片阴性标本中HRM检测利福平、katG、inhA耐药灵敏度分别为89%、85%、100%。
- HRM与测序结果一致性达97%至100%,特异性均为100%。
核心结论
- HRM是一种成本效益高、快速、闭管式的方法,可直接检测痰中MDR-TB,尤其适用于涂片阴性病例。
研究设计与样本
- 研究先构建参考质粒库作为阳性对照,在25株MDR结核临床分离株中验证HRM,再以DNA测序为金标准评估99份培养阳性痰标本(含84份涂片阴性)。
主要发现
- HRM在涂片阴性样本中检测利福平、katG和inhA耐药的灵敏度分别为89%(95%CI 52-100%)、85%(95%CI 62-97%)和100%(95%CI 74-100%)。
- 涂片阳性样本中所有HRM检测灵敏度均为100%,所有检测特异性均为100%。
- HRM与测序一致性为97%至100%(κ值0.9至1),测序发现5/99份样本存在异质性耐药。
关键数值与推荐
- HRM检测利福平耐药灵敏度在涂片阴性样本为89%(95%CI 52-100%),涂片阳性为100%。
- HRM检测katG耐药灵敏度在涂片阴性样本为85%(95%CI 62-97%),涂片阳性为100%。
- HRM检测inhA耐药灵敏度在涂片阴性样本为100%(95%CI 74-100%),涂片阳性为100%。
- 所有HRM检测特异性均为100%,与测序一致性97%至100%(κ值0.9至1)。
临床怎么用
- HRM可作为痰标本直接检测MDR-TB的快速方法,尤其适用于涂片阴性病例,成本为400印度卢比/6美元。
局限性
- HRM漏检了1例测序分类为MDR-TB的样本,测序发现5/99份样本存在异质性耐药。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Drug-resistant tuberculosis (TB) is a major threat to TB control worldwide. Globally, only 40% of the 340,000 notified TB patients estimated to have multidrug-resistant-TB (MDR-TB) were detected in 2015. This study was carried out to evaluate the utility of high-resolution melt curve analysis (HRM) for the rapid and direct detection of MDR-TB in Mycobacterium tuberculosis in sputum samples. A reference plasmid library was first generated of the most frequently observed mutations in the resistance-determining regions of rpoB, katG, and an inhA promoter and used as positive controls in HRM. The assay was first validated in 25 MDR M. tuberculosis clinical isolates. The assay was evaluated on DNA isolated from 99 M. tuberculosis culture-positive sputum samples that included 84 smear-negative sputum samples, using DNA sequencing as gold standard. Mutants were discriminated from the wild type by comparing melting-curve patterns with those of control plasmids using HRM software. Rifampin (RIF) and isoniazid (INH) monoresistance were detected in 11 and 21 specimens, respectively, by HRM. Six samples were classified as MDR-TB by sequencing, one of which was missed by HRM. The HRM-RIF, INH-katG, and INH-inhA assays had 89% (95% confidence interval [CI], 52, 100%), 85% (95% CI, 62, 97%), and 100% (95% CI, 74, 100%) sensitivity, respectively, in smear-negative samples, while all assays had 100% sensitivity in smear-positive samples. All assays had 100% specificity. Concordance of 97% to 100% (κ value, 0.9 to 1) was noted between sequencing and HRM. Heteroresistance was observed in 5 of 99 samples by sequencing. In conclusion, the HRM assay was a cost-effective (Indian rupee [INR]400/US$6), rapid, and closed-tube method for the direct detection of MDR-TB in sputum, especially for direct smear-negative cases.
引用
- Anthwal D, Gupta RK, Bhalla M, et al. Direct Detection of Rifampin and Isoniazid Resistance in Sputum Samples from Tuberculosis Patients by High-Resolution Melt Curve Analysis. J Clin Microbiol. 2017. PMID: 28330890. doi:10.1128/JCM.02104-16
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。